Construction of a 2.5D Deep Learning Model for Predicting Early Postoperative Recurrence of Hepatocellular Carcinoma Using Multi-View and Multi-Phase CT Images
Yu-Bo Zhang,Zhi-Qiang Chen,Yang Bu,Peng Lei,Wei Yang,Wei Zhang
DOI: https://doi.org/10.2147/jhc.s493478
2024-11-22
Journal of Hepatocellular Carcinoma
Abstract:Yu-Bo Zhang, 1, 2 Zhi-Qiang Chen, 1, 3 Yang Bu, 2 Peng Lei, 2 Wei Yang, 4 Wei Zhang 2 1 School of Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, People's Republic of China; 2 Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China; 3 Department of Hepatobiliary Surgery, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, 750002, People's Republic of China; 4 Department of Radiology, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China Correspondence: Peng Lei, Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, No. 804 Shengli Nan Street, Yinchuan, 750004, People's Republic of China, Email Yang Bu, Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, No. 804 Shengli Nan Street, Yinchuan, 750004, People's Republic of China, Email Purpose: To construct a 2.5-dimensional (2.5D) CT radiomics-based deep learning (DL) model to predict early postoperative recurrence of hepatocellular carcinoma (HCC). Patients and Methods: We retrospectively analyzed the data of patients who underwent HCC resection at 2 centers. The 232 patients from center 1 were randomly divided into the training (162 patients) and internal validation cohorts (70 patients); 91 patients from center 2 formed the external validation cohort. We developed a 2.5D DL model based on a central 2D image with the maximum tumor cross-section and adjacent slices. Multiple views (transverse, sagittal, and coronal) and phases (arterial, plain, and portal) were incorporated. Multi-instance learning techniques were applied to the extracted data; the resulting comprehensive feature set was modeled using Logistic Regression, RandomForest, ExtraTrees, XGBoost, and LightGBM, with 5-fold cross validation and hyperparameter optimization with Grid-search. Receiver operating characteristic curves, calibration curves, DeLong test, and decision curve analysis were used to evaluate model performance. Results: The 2.5D DL model performed well in the training (AUC: 0.920), internal validation (AUC: 0.825), and external validation cohorts (AUC: 0.795). The 3D DL model performed well in the training cohort and poorly in the internal and external validation cohorts (AUCs: 0.751, 0.666, and 0.567, respectively), indicating overfitting. The combined model (2.5D DL+clinical) performed well in all cohorts (AUCs: 0.921, 0.835, 0.804). The Hosmer-Lemeshow test, DeLong test, and decision curve analysis confirmed the superiority of the combined model over the other signatures. Conclusion: The combined model integrating 2.5D DL and clinical features accurately predicts early postoperative HCC recurrence. Keywords: hepatocellular carcinoma, liver resection, deep learning, computed tomography, recurrence Liver resection and liver transplantation are preferred surgical treatments for early hepatocellular carcinoma (HCC), with comparable outcomes; 1 however, these treatments are associated with a high postoperative recurrence rate of approximately 50%–70%, which significantly impacts the postoperative survival rate and contributes to a poor prognosis. 2,3 Studies have shown that early recurrence, occurring within 2 years after surgery, accounts for 61.4%–83.3% of all postoperative recurrences, 4,5 and is associated with worse postoperative survival rates. 6,7 Therefore, the early identification of patients who are at high risk for early recurrence and the implementation of appropriate preventive measures has become a research hotspot in the field of liver cancer research. Numerous studies have identified risk factors for postoperative HCC recurrence, such as microvascular invasion (MVI), pathological differentiation, alpha-fetoprotein level, and tumor size. 8–11 However, the evaluation of these factors requires invasive procedures or postoperative pathological specimens; moreover, these factors do not fully reflect the heterogeneity of solid tumors. 12–14 Consequently, conventional imaging examinations and oncological markers have limitations in promptly diagnosing HCC recurrence and guiding individualized precise prevention and treatment strategies against early recurrence. In recent years, radiomics has emerged as a non-invasive technique that shows great potential in predicting cancer outcomes based on quantitative analysis. 15 Radiomics techniques can efficiently extract a wide range of imaging features from medical images in a high-throughput manner. The extracted features, such as texture, gray level, intensi -Abstract Truncated-
oncology